Literature DB >> 30192523

Targeting Metalloenzymes for Therapeutic Intervention.

Allie Y Chen1, Rebecca N Adamek1, Benjamin L Dick1, Cy V Credille1, Christine N Morrison1, Seth M Cohen1.   

Abstract

Metalloenzymes are central to a wide range of essential biological activities, including nucleic acid modification, protein degradation, and many others. The role of metalloenzymes in these processes also makes them central for the progression of many diseases and, as such, makes metalloenzymes attractive targets for therapeutic intervention. Increasing awareness of the role metalloenzymes play in disease and their importance as a class of targets has amplified interest in the development of new strategies to develop inhibitors and ultimately useful drugs. In this Review, we provide a broad overview of several drug discovery efforts focused on metalloenzymes and attempt to map out the current landscape of high-value metalloenzyme targets.

Mesh:

Substances:

Year:  2018        PMID: 30192523      PMCID: PMC6405328          DOI: 10.1021/acs.chemrev.8b00201

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


  1158 in total

1.  Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships.

Authors:  C L Strickland; P C Weber; W T Windsor; Z Wu; H V Le; M M Albanese; C S Alvarez; D Cesarz; J del Rosario; J Deskus; A K Mallams; F G Njoroge; J J Piwinski; S Remiszewski; R R Rossman; A G Taveras; B Vibulbhan; R J Doll; V M Girijavallabhan; A K Ganguly
Journal:  J Med Chem       Date:  1999-06-17       Impact factor: 7.446

2.  Peptide aldehyde inhibitors of bacterial peptide deformylases.

Authors:  D J Durand; B Gordon Green; J F O'Connell; S K Grant
Journal:  Arch Biochem Biophys       Date:  1999-07-15       Impact factor: 4.013

3.  RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Authors:  V Dive; J Cotton; A Yiotakis; A Michaud; S Vassiliou; J Jiracek; G Vazeux; M T Chauvet; P Cuniasse; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Structural basis for the design of antibiotics targeting peptide deformylase.

Authors:  B Hao; W Gong; P T Rajagopalan; Y Zhou; D Pei; M K Chan
Journal:  Biochemistry       Date:  1999-04-13       Impact factor: 3.162

5.  Chicoric acid analogues as HIV-1 integrase inhibitors.

Authors:  Z Lin; N Neamati; H Zhao; Y Kiryu; J A Turpin; C Aberham; K Strebel; K Kohn; M Witvrouw; C Pannecouque; Z Debyser; E De Clercq; W G Rice; Y Pommier; T R Burke
Journal:  J Med Chem       Date:  1999-04-22       Impact factor: 7.446

6.  Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesis.

Authors:  M H Chen; M G Steiner; S E de Laszlo; A A Patchett; M S Anderson; S A Hyland; H R Onishi; L L Silver; C R Raetz
Journal:  Bioorg Med Chem Lett       Date:  1999-02-08       Impact factor: 2.823

7.  Escherichia coli methionine aminopeptidase: implications of crystallographic analyses of the native, mutant, and inhibited enzymes for the mechanism of catalysis.

Authors:  W T Lowther; A M Orville; D T Madden; S Lim; D H Rich; B W Matthews
Journal:  Biochemistry       Date:  1999-06-15       Impact factor: 3.162

8.  The crystal structure of Escherichia coli class II fructose-1, 6-bisphosphate aldolase in complex with phosphoglycolohydroxamate reveals details of mechanism and specificity.

Authors:  D R Hall; G A Leonard; C D Reed; C I Watt; A Berry; W N Hunter
Journal:  J Mol Biol       Date:  1999-03-26       Impact factor: 5.469

9.  Design and synthesis of substrate analogue inhibitors of peptide deformylase.

Authors:  T Meinnel; L Patiny; S Ragusa; S Blanquet
Journal:  Biochemistry       Date:  1999-04-06       Impact factor: 3.162

Review 10.  Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.

Authors:  T J Torphy; M S Barnette; D C Underwood; D E Griswold; S B Christensen; R D Murdoch; R B Nieman; C H Compton
Journal:  Pulm Pharmacol Ther       Date:  1999       Impact factor: 3.410

View more
  41 in total

1.  Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.

Authors:  Allie Y Chen; Pei W Thomas; Zishuo Cheng; Nasa Y Xu; David L Tierney; Michael W Crowder; Walter Fast; Seth M Cohen
Journal:  ChemMedChem       Date:  2019-05-24       Impact factor: 3.466

2.  Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.

Authors:  Lucy Lin; Margaret E Olson; Takashi Sugane; Lewis D Turner; Margarita A Tararina; Alexander L Nielsen; Elbek K Kurbanov; Sabine Pellett; Eric A Johnson; Seth M Cohen; Karen N Allen; Kim D Janda
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

3.  Shedding light on RNaseH: a promising target for hepatitis B virus (HBV).

Authors:  Tiffany C Edwards; Nathan L Ponzar; John E Tavis
Journal:  Expert Opin Ther Targets       Date:  2019-05-22       Impact factor: 6.902

Review 4.  Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit.

Authors:  Elizabeth W Hunsaker; Katherine J Franz
Journal:  Inorg Chem       Date:  2019-06-19       Impact factor: 5.165

5.  Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.

Authors:  Matthew J Mitcheltree; Derun Li; Abdelghani Achab; Adam Beard; Kalyan Chakravarthy; Mangeng Cheng; Hyelim Cho; Padmanabhan Eangoor; Peter Fan; Symon Gathiaka; Hai-Young Kim; Charles A Lesburg; Thomas W Lyons; Theodore A Martinot; J Richard Miller; Spencer McMinn; Jennifer O'Neil; Anandan Palani; Rachel L Palte; Josep Saurí; David L Sloman; Hongjun Zhang; Jared N Cumming; Christian Fischer
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

6.  Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.

Authors:  Cy V Credille; Benjamin L Dick; Christine N Morrison; Ryjul W Stokes; Rebecca N Adamek; Nicholas C Wu; Ian A Wilson; Seth M Cohen
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

Review 7.  Tools and techniques for illuminating the cell biology of zinc.

Authors:  Evan P S Pratt; Leah J Damon; Kelsie J Anson; Amy E Palmer
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-09-24       Impact factor: 4.739

8.  Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication.

Authors:  Qilan Li; Elena Lomonosova; Maureen J Donlin; Feng Cao; Austin O'Dea; Brienna Milleson; Alex J Berkowitz; John-Charles Baucom; John P Stasiak; Daniel V Schiavone; Rudolf G Abdelmessih; Anastasiya Lyubimova; Americo J Fraboni; Lauren P Bejcek; Juan A Villa; Emilio Gallicchio; Ryan P Murelli; John E Tavis
Journal:  Antiviral Res       Date:  2020-03-23       Impact factor: 5.970

9.  Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species.

Authors:  Erofili Giannakopoulou; Vasiliki Pardali; Efseveia Frakolaki; Vasileios Siozos; Vassilios Myrianthopoulos; Emmanuel Mikros; Martin C Taylor; John M Kelly; Niki Vassilaki; Grigoris Zoidis
Journal:  Medchemcomm       Date:  2019-05-16       Impact factor: 3.597

10.  Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach.

Authors:  Lewis D Turner; Alexander L Nielsen; Lucy Lin; Sabine Pellett; Takashi Sugane; Margaret E Olson; Eric A Johnson; Kim D Janda
Journal:  RSC Med Chem       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.